The first recommended malaria vaccine, developed by GSK. It reduces severe malaria hospital admissions by roughly 30% to stabilize health outcomes.
The first recommended malaria vaccine, developed by GSK. It reduces severe malaria hospital admissions by roughly 30% to stabilize health outcomes.